The W.A.I.O.T. Definition of Peri-Prosthetic Joint Infection: A Multi-center, Retrospective Validation Study
Abstract
:1. Introduction
2. Material and Methods
2.1. Pre/Intra-Operative Assessment and Post-Operative Validation
2.2. Statistical Analysis
3. Results
4. Discussion
5. Study Limitations
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Honkanen, M.; Jämsen, E.; Karppelin, M.; Huttunen, R.; Lyytikäinen, O.; Syrjänen, J. Concordance between the old and new diagnostic criteria for periprosthetic joint infection. Infection 2017, 45, 637–643. [Google Scholar] [CrossRef]
- Horan, T.C.; Gaynes, R.P.; Martone, W.J.; Jarvis, W.R.; Emori, T.G. CDC definitions of nosocomial surgical site infections, 1992: A modification of CDC definitions of surgical wound infections. Infect. Control Hosp. Epidemiol. 1992, 13, 606–608. [Google Scholar] [CrossRef] [PubMed]
- Fernandez-Sampedro, M.; Farinas-Alvarez, C.; Garces-Zarzalejo, C.; Alonso-Aguirre, M.A.; Salas-Venero, C.; Martínez-Martínez, L.; Fariñas, M.C. Accuracy of different diagnostic tests for early, delayed and late prosthetic joint infection. BMC Infect. Dis. 2017, 17, 592. [Google Scholar] [CrossRef] [Green Version]
- Ahmad, S.S.; Shaker, A.; Saffarini, M.; Chen, A.F.; Hirschmann, M.T.; Kohl, S. Accuracy of diagnostic tests for prosthetic joint infection: A systematic review. Knee Surg. Sports Traumatol. Arthrosc. J. ESSKA 2016, 24, 3064–3074. [Google Scholar] [CrossRef]
- Pérez-Prieto, D.; Portillo, M.E.; Puig-Verdié, L.; Alier, A.; Martínez, S.; Sorlí, L.; Horcajada, J.P.; Monllau, J.C. C-reactive protein may misdiagnose prosthetic joint infections, particularly chronic and low-grade infections. Int. Orthop. 2017, 41, 1315–1319. [Google Scholar] [CrossRef]
- Romanò, C.L.; Romanò, D.; Morelli, I.; Drago, L. The concept of biofilm-related implant malfunction and “low-grade infection”. Adv. Exp. Med. Biol. 2017, 971, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Parvizi, J.; Tan, T.L.; Goswami, K.; Higuera, C.; Della Valle, C.; Chen, A.F.; Shohat, N. The 2018 definition of periprosthetic hip and knee infection: An evidence-based and validated criteria. J. Arthroplast. 2018, 33, 1309–1314. [Google Scholar] [CrossRef]
- Baumbach, S.F.; Prall, W.C.; Scharpf, A.M.; Hererich, V.; Schmidt, M.; Suedkamp, N.P.; Stoehr, A.; Mayr, H.O. Significant increase of pathogen detection rate by dry arthroscopic biopsies at suspected low-grade infection following total knee arthroplasty: A prospective observational study. Arch. Orthop. Trauma Surg. 2018, 138, 1583–1590. [Google Scholar] [CrossRef]
- Morgenstern, C.; Cabric, S.; Perka, C.; Trampuz, A.; Renz, N. Synovial fluid multiplex PCR is superior to culture for detection of low-virulent pathogens causing periprosthetic joint infection. Diagn. Microbiol. Infect. Dis. 2018, 90, 115–119. [Google Scholar] [CrossRef]
- Goswami, K.; Parvizi, J.; Maxwell Courtney, P. Current recommendations for the diagnosis of acute and chronic PJI for hip and knee-cell counts, alpha-defensin, leukocyte esterase, next-generation sequencing. Curr. Rev. Musculoskelet. Med. 2018, 11, 428–438. [Google Scholar] [CrossRef]
- Signore, A.; Sconfienza, L.M.; Borens, O.; Glaudemans, A.W.J.M.; Cassar-Pullicino, V.; Trampuz, A.; Winkler, H.; Gheysens, O.; Vanhoenacker, F.M.H.M.; Petrosillo, N.; et al. Consensus document for the diagnosis of prosthetic joint infections: A joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement). Eur. J. Nucl. Med. Mol. Imaging 2019, 26, 971–988. [Google Scholar] [CrossRef] [Green Version]
- Parvizi, J.; Gehrke, T. Proceedings of the Second International Consensus Meeting on Musculoskeletal Infection; Hip and Knee Section—Data Trace Publishing Company: Brooklandville, MD, USA, 2018; ISBN 978-1-57400-157-0. [Google Scholar]
- Parvizi, J.; Zmistowski, B.; Berbari, E.F.; Bauer, T.W.; Springer, B.D.; Della Valle, C.J.; Garvin, K.L.; Mont, M.A.; Wongworawat, M.D.; Zalavras, C.G. New definition for periprosthetic joint infection: From the workgroup of the Musculoskeletal infection Society. Clin. Orthop. Relat. Res. 2011, 469, 2992–2994. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Osmon, D.R.; Berbari, E.F.; Berendt, A.R.; Lew, D.; Zimmerli, W.; Steckelberg, J.M.; Rao, N.; Hanssen, A.; Wilson, W.R.; Infectious diseases society of America. Diagnosis and management of prosthetic joint infection: Clinical practice guidelines by the infectious diseases society of America. Clin. Infect. Dis. 2013, 56, 1–25. [Google Scholar] [CrossRef] [Green Version]
- Parvizi, J.; Gehrke, T. Definition of periprosthetic joint infection. J. Arthroplast. 2014, 29, 1331. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Renz, N.; Yermak, K.; Perka, C.; Trampuz, A. Alpha defensin lateral flow test for diagnosis of periprosthetic joint infection: Not a screening but a confirmatory test. J. Bone Jt. Surg. Am. 2018, 100, 742–750. [Google Scholar] [CrossRef] [PubMed]
- Romanò, C.L.; Khawashki, H.A.; Benzakour, T.; Bozhkova, S.; Del, S.H.; Hafez, M.; Johari, A.; Lob, G.; Sharma, H.K.; Tsuchiya, H.; et al. The W.A.I.O.T. definition of high-grade and low-grade peri-prosthetic joint infection. J. Clin. Med. 2019, 8, 650. [Google Scholar] [CrossRef] [Green Version]
- Kwiecien, G.; George, J.; Klika, A.K.; Zhang, Y.; Bauer, T.W.; Rueda, C.A. Intraoperative frozen section histology: Matched for musculoskeletal infection society criteria. J. Arthroplast. 2017, 32, 223–227. [Google Scholar] [CrossRef]
- Villa, J.M.; Pannu, T.S.; Piuzzi, N.; Riesgo, A.M.; Higuera, C.A. Evolution of diagnostic definitions for periprosthetic joint infection in total hip and knee arthroplasty. J. Arthroplast. 2020, 35, 9–13. [Google Scholar] [CrossRef]
- Gbejuade, H.O.; Lovering, A.M.; Webb, J.C. The role of microbial biofilms in prosthetic joint infections. Acta Orthop. 2015, 86, 147–158. [Google Scholar] [CrossRef]
- Neut, D.; van der Mei, H.C.; Bulstra, S.K.; Busscher, H.J. The role of small-colony variants in failure to diagnose and treat biofilm infections in orthopedics. Acta Orthop. 2007, 78, 299–308. [Google Scholar] [CrossRef] [Green Version]
- Yang, D.; Wijenayaka, A.R.; Solomon, L.B.; Pederson, S.M.; Findlay, D.M.; Kidd, S.P.; Atkins, G.J. Novel insights into staphylococcus aureus deep bone infections: The involvement of osteocytes. MBio 2018, 9, 415–418. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Moojen, D.J.; van Hellemondt, G.; Vogely, H.C.; Burger, B.J.; Walenkamp, G.H.I.M.; Tulp, N.J.A.; Schreurs, B.W.; de Meulemeester, F.R.A.J.; Schot, C.S.; van de Pol, I. Incidence of low-grade infection in aseptic loosening of total hip arthroplasty. Acta Orthop. 2010, 81, 667–673. [Google Scholar] [CrossRef]
- Millett, P.J.; Yen, Y.M.; Price, C.S.; Horan, M.P.; van der Meijden, O.A.; Elser, F. Propionibacterium acnes infection as an occult cause of postoperative shoulder pain: A case series. Clin. Orthop. Relat. Res. 2011, 469, 2824–2830. [Google Scholar] [CrossRef] [Green Version]
- Beswick, A.D.; Wylde, V.; Gooberman-Hill, R.; Blom, A.; Dieppe, P. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open 2012, 2, 435. [Google Scholar] [CrossRef]
- Gallazzi, E.; Drago, L.; Baldini, A.; Stockley, I.; George, D.A.; Scarponi, S.; Romanò, C.L. “Combined Diagnostic Tool” APPlication to a Retrospective Series of Patients Undergoing Total Joint Revision Surgery. J. Bone Jt. Infect. 2017, 2, 107–113. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Boettner, F.; Koehler, G.; Wegner, A.; Schmidt-Braekling, T.; Gosheger, G.; Goetze, C. The rule of histology in the diagnosis of periprosthetic infection: Specific granulocyte counting methods and new immunohistologic staining techniques may increase the diagnostic value. Open Orthop. J. 2016, 10, 457–465. [Google Scholar] [CrossRef] [Green Version]
- Peel, T.N.; Spelman, T.; Dylla, B.L.; Hughes, J.G.; Greenwood-Quaintance, K.E.; Cheng, A.C.; Mandrekar, J.N.; Patel, R. Optimal periprosthetic tissue specimen number for diagnosis of prosthetic joint infection. J. Clin. Microbiol. 2016, 55, 234–243. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tan, T.L.; Kheir, M.M.; Shohat, N.; Tan, D.D.; Kheir, M.; Chen, C.; Parvizi, J. Culture-Negative Periprosthetic Joint Infection: An update on What to Expect. JB JS Open Access 2018, 3, 60. [Google Scholar] [CrossRef]
- Sambri, A.; Cadossi, M.; Giannini, S.; Pignatti, G.; Marcacci, M.; Neri, M.P.; Maso, A.; Storni, E.; Gamberini, S.; Naldi, S.; et al. Is treatment with dithiothreitol more effective than sonication for the diagnosis of prosthetic joint infection? Clin. Orthop. Relat. Res. 2018, 476, 137–145. [Google Scholar] [CrossRef]
- Drago, L.; Clerici, P.; Morelli, I.; Ashok, J.; Benzakour, T.; Bozhkova, S.; Alizadeh, C.; Del, S.H.; Sharma, H.K.; Peel, T.; et al. The world association against infection in orthopaedics and trauma (WAIOT) procedures for microbiological sampling and processing for periprosthetic joint infections (PJIs) and other implant-related infections. J. Clin. Med. 2019, 8, 933. [Google Scholar] [CrossRef] [Green Version]
- Li, C.; Renz, N.; Thies, C.O.; Trampuz, A. Meta-analysis of sonicate fluid in blood culture bottles for diagnosing periprosthetic joint infection. J. Bone Jt. Infect. 2018, 3, 273–279. [Google Scholar] [CrossRef] [Green Version]
- Bémer, P.; Plouzeau, C.; Tande, D.; Léger, J.; Giraudeau, B.; Valentin, A.S.; Jolivet-Gougeon, A.; Vincent, P.; Corvec, S.; Gibaud, S.; et al. Evaluation of 16S rRNA gene PCR sensitivity and specificity for diagnosis of prosthetic joint infection: A prospective multicentre cross-sectional study. J. Clin. Microbiol. 2014, 52, 3583–3589. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shohat, N.; Bauer, T.; Buttaro, M.; Budhiparama, N.; Cashman, J.; Della, V.C.J.; Drago, L.; Gehrke, T.; Marcelino, G.L.S.; Goswami, K.; et al. Hip and knee section, what is the definition of a periprosthetic joint infection (PJI) of the knee and the hip? Can the same criteria be used for both joints? Proceedings of the international consensus on orthopedic infections. J. Arthroplast. 2019, 34, 325–327. [Google Scholar] [CrossRef] [PubMed]
- Fu, D.; Sun, W.; Shen, J.; Ma, X.; Cai, Z.; Hua, Y. Inflammatory pseudotumor around metal-on-polyethylene total hip arthroplasty in patients with ankylosing spondylitis: Description of two cases and review of literature. World J. Surg. Oncol. 2015, 13, 57. [Google Scholar] [CrossRef] [Green Version]
- Li, C.; Renz, N.; Trampuz, A. Management of periprosthetic joint infection. Hip Pelvis 2018, 30, 138–146. [Google Scholar] [CrossRef] [PubMed]
- Adams, J.R.; Schwartz, A.J. False-negative synovial alpha-defensin. Arthroplast. Today 2017, 3, 239–241. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Saeed, K. Diagnostics in prosthetic joint infections. J. Antimicrob. Chemother. 2014, 69, 11–19. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Stone, W.Z.; Gray, C.F.; Parvataneni, H.K.; Al-Rashid, M.; Vlasak, R.G.; Horodyski, M.; Prieto, H.A. Clinical evaluation of synovial alpha defensin and synovial c-reactive protein in the diagnosis of periprosthetic joint infection. J. Bone Jt. Surg. Am. 2018, 18, 1184–1190. [Google Scholar] [CrossRef] [PubMed]
- Sigmund, I.K.; Yermak, K.; Perka, C.; Trampuz, A.; Renz, N. Is the enzyme-linked immunosorbent assay more accurate than the lateral flow alpha defensin test for diagnosing periprosthetic joint infection? Clin. Orthop. Relat. Res. 2018, 476, 1645–1654. [Google Scholar] [CrossRef]
- Gehrke, T.; Lausmann, C.; Citak, M.; Bonanzinga, T.; Frommelt, L.; Zahar, A. The accuracy of the alpha defensin lateral flow device for diagnosis of periprosthetic joint infection: Comparison with a gold standard. J. Bone Jt. Surg. Am. 2018, 100, 42–48. [Google Scholar] [CrossRef]
- Verberne, S.J.; Sonnega, R.J.; Temmerman, O.P.; Raijmakers, P.G. What is the accuracy of nuclear imaging in the assessment of periprosthetic knee infection? A meta-analysis. Clin. Orthop. Relat. Res. 2017, 475, 1395–1410. [Google Scholar] [CrossRef] [PubMed] [Green Version]
MSIS 2018 Criteria for PJI [7] | ICM Criteria for PJI [12] |
---|---|
Major Criteria (at least one of the following) | Major Criteria (at least one of the following) |
|
|
Decision: Infected | Decision: Infected |
Minor Criteria | Minor Criteria |
Preoperative Diagnosis:
| Combined preoperative and postoperative score:
|
Decision: | Decision: |
≥6 Infected | ≥6 Infected |
2–5 Possibly Infected (“Consider further molecular diagnostics such as next-generation sequencing”) | 3–5 Inconclusive (“Consider further molecular diagnostics such as next-generation sequencing”) |
0–1 Not Infected. | <3 Not Infected. |
Inconclusive pre-op score or dry tap
| |
Decision: ≥6 Infected 4–5 Inconclusive (“Consider further molecular diagnostics such as next-generation sequencing”) <3 Not Infected. |
No Infection | Contamination | BIM | LG-PJI | HG-PJI | |
---|---|---|---|---|---|
Clinical presentation | One or more condition(s), other than infection, can cause the symptoms or the reason for reoperation (e.g., wear debris, metallosis, recurrent dislocation or joint instability, fracture, malposition, neuropathic pain) | One or more of the followings: Otherwise “unexplained” pain, swelling, stiffness | Two or more of the followings: Pain, swelling, redness, warmth, functio laesa | ||
Number of Positive Rule In Minus Number of Negative Rule Out tests | <0 | <0 | <0 | ≥0 | ≥1 |
Post-Operatively Confirmed If | Negative cultural examination | One pre- or intra-operative positive culture, with negative histology | Positive cultural examination (preferably with anti-biofilm techniques) and/or positive histology |
Rule OUT Tests Each Negative Test Scores −1 (Positive Rule Out Tests Score 0) | |
Serum | ESR (>30 mm/h) CRP (>10 mg/L) |
Synovial fluid | WBC (>1500/μL) LE (++) Alpha-Defensin immunoassay (>5.2 mg/L) |
Imaging | Tc99 bone scan |
Rule IN Tests Each Positive Test Scores +1 (Negative Rule In Tests Score 0) | |
Clinical examination | Draining sinus or exposed joint prosthesis |
Serum | IL-6 (>10 pg/mL) PC (>0.5 ng/mL) D-Dimer (>850 ng/mL) |
Synovial fluid | Cultural examination WBC (>3000/mL) LE (++) Alpha-defensin immunoassay (>5.2 mg/L) or lateral flow test |
Imaging | Combined leukocyte and bone marrow scintigraphy |
Histology | Frozen section (5 neutrophils in at least 3 HPFs) |
Patients | Hip Prosthesis | Knee Prosthesis | One-Stage Revision | Two-Stage Revision | Number of Performed Rule in Tests | Number of Performed Rule in Tests Per Patient | Number of Performed Rule out Tests | Number of Performed Rule out Tests Per Patient | Pre/Intra-Operative Score | |
---|---|---|---|---|---|---|---|---|---|---|
(n and %) | (n and %) | (n and %) | (n and %) | (n and %) | (n) | (mean ± SD and range) | (n) | (mean ± SD and range) | (mean ± SD and range) | |
HG-PJI | 76 (36.2) | 37 (48.7) | 39 (51.3) | 19 (25.0) | 57 (75) | 193 | 2.5 ± 0.9 (2–6) | 222 | 2.5 ± 1.0 (2–5) | 2.3 ± 0.8 (1–4) |
LG-PJI | 46 (21.9) | 19 (41.3) | 27 (58.7) | 15 (32.6) | 31 (67.4) | 113 | 2.5 ± 0.7 (2–4) | 156 | 3.0 ± 1.2 (2–5) | 0.8 ± 0.8 (0–2) |
BIM | 22 (10.5) | 6 (27.3) | 16 (72.7) | 8 (36.4) | 14 (63.6) | 50 | 2.3 ± 0.7 (2–4) | 69 | 3.1 ± 1.2 (2–5) | −1.6 ± 0.8 (–3–−1) |
Contamination | 6 (2.9) | 1 (16.7) | 5 (83.3) | 6 (100) | 0 (0) | 18 | 2.8 ± 1.0 (2–4) | 27 | 4.3 ± 0.8 (3–5) | –3.5 ± 1.0 (–5–−2) |
No Infection | 60 (28.6) | 23 (38.3) | 37 (61.7) | 43 (71.7) | 17 (28.3) | 186 | 3.1 ± 0.9 (2–5) | 243 | 3.9 ± 1.2 (2–5) | –3.0 ± 1.4 (–5–−1) |
TOTAL | 210 (100) | 86 (40.9) | 124 (59.0) | 91 (43.3) | 119 (56.7) | 560 | 2.7 ± 0.9 (2–6) | 717 | 3.1 ± 1.1 (2–5) | –0.1 ± 2.5 (–5–4) |
HG-PJI (n = 76) | LG-PJI (n = 46) | BIM (n = 22) | Contamination (n = 6) | No infection (n = 60) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Positive Tests/Performed Tests | % | Positive Tests/Performed Tests | % | Positive Tests/Performed Tests | % | Positive Tests/Performed Tests | % | Positive Tests/Performed Tests | % | ||
Physical examination | Fistula | 30/76 | 39.5 | 5/46 | 10.9 | 2/22 | 9.1 | 0/6 | 0 | 0/60 | 0 |
Serum markers | CRP > 10 mg/L | 71/76 | 93.4 | 37/46 | 80.4 | 5/22 | 22.7 | 1/6 | 16.7 | 10/60 | 16.7 |
ESR > 30 mm/hr | 56/62 | 90.3 | 37/45 | 82.2 | 10/19 | 52.6 | 1/6 | 16.7 | 11/54 | 20.4 | |
IL-6 > 10 pg/mL | 1/1 | 100 | 0/0 | n/a | 0/0 | n/a | 0/0 | n/a | 0/0 | n/a | |
PC > 0.5 ng/mL | 4/4 | 100 | 0/1 | 0.0 | 0/1 | 0.0 | 0/0 | n/a | 0/4 | 0.0 | |
D-dimer > 850 ng/mL | 21/31 | 67.7 | 2/14 | 14.3 | 0/9 | 0.0 | 0/2 | 0.0 | 0/13 | 0.0 | |
Synovial fluid markers | WBC > 3000/mcL | 22/25 | 88.0 | 16/23 | 69.6 | 0/7 | 0.0 | 0/5 | 0.0 | 2/47 | 4.3 |
WBC > 1500/mcL | 24/25 | 96.0 | 17/23 | 73.9 | 5/7 | 71.4 | 1/5 | 20.0 | 2/47 | 4.3 | |
LE ++ | 36/43 | 83.7 | 11/23 | 47.8 | 2/13 | 15.4 | 0/6 | 0.0 | 3/48 | 6.3 | |
Alpha-defensin >5.2 mg/L or lateral flow test | 8/9 | 88.9 | 1/4 | 25.0 | 0/2 | 0.0 | 0/2 | 0.0 | 0/25 | 0.0 | |
Imaging | Tc99 Bone scan | 6/7 | 85.7 | 15/15 | 100 | 6/6 | 100 | 2/2 | 100 | 9/9 | 100 |
Combined Leukocyte/ Bone Marrow scintigraphy | 15/16 | 93.8 | 12/14 | 85.7 | 1/3 | 33.3 | 1/1 | 100 | 3/4 | 75.0 | |
Microbiology | Cultural examination | 34/42 | 81.0 | 15/31 | 48.4 | 4/14 | 28.6 | 0/2 | 0.0 | 7/38 | 18.4 |
Histology | Frozen sections | 21/22 | 95.5 | 0/3 | 0.0 | 1/1 | 100 | 0/0 | n/a | 0/7 | 0.0 |
TOTAL excl. fistula | 363/415 | 87.5 | 176/269 | 65.4 | 36/119 | 30.3 | 9/45 | 20.0 | 49/429 | 11.4 | |
TOTAL | 303/491 | 80.0 | 181/315 | 57.5 | 38/141 | 27.0 | 9/51 | 17.6 | 49/489 | 10.0 |
Patients | Pre/Intra-Operative Score | Post-Operative Positive Cultural Examination | Post-Operative Positive Histology | Post-Operative Confirmed Pre/Intra-Operative Definition | |
---|---|---|---|---|---|
(n and %) | (mean ± SD and range) | (Positive tests/tests performed and %) | (Positive tests /tests performed and %) | (n and %) | |
HG-PJI | 76 (36.2) | 2.3 ± 0.8 (1–4) | 74/76 (97.3) | 41/48 (85.4) | 76/76 (100) |
LG-PJI | 46 (21.9) | 0.8 ± 0.8 (0–2) | 29/46 (63.0) | 23/34 (67.6) | 41/46 (89.1) |
BIM | 22 (10.5) | –1.6 ± 0.8 (–3–1) | 17/22 (77.3) | 9/16 (57.2) | 22/22 (100) |
Contamination | 6 (2.9) | –3.5 ± 1.0 (–5–2) | 6/6 (100) | 0/3 (0) | 6/6 (100) |
No Infection | 60 (28.6) | –3.0 ± 1.4 (–5–1) | 0/60 (0) | 1/46 (2.2) | 59/60 (98.3) |
TOTAL | 210(100) | –0.1 ± 2.5 (–5–4) | 126/210 (60.0) | 74/147 (50.3) | 204/210 (97.1) |
Patient | 1 | 2 | 3 | 4 | 5 | 6 | ||
---|---|---|---|---|---|---|---|---|
Clinical examination | Fistula | Negative | Negative | Negative | Negative | Negative | Negative | |
Serum | CRP ESR | Negative | Positive | Positive | Negative | Positive | Negative | |
Negative | Positive | Negative | Positive | Positive | ||||
Synovial fluid | WBC LE | Negative | Positive | Negative | Positive | |||
Negative | Negative | Positive | Positive | Positive | ||||
Cultural examination | Positive | Positive | Positive | |||||
Alpha-defensin | Negative | |||||||
Imaging | Tc99 Bone scan | Positive | Positive | |||||
Leukocyte/Bone Marrow scintigraphy | Positive | Positive | ||||||
Positive rule in tests Score | 0 | 2 | 1 | 3 | 2 | 2 | ||
Negative rule out tests Score | –4 | 0 | –1 | –2 | –1 | –2 | ||
Pre/intra-operative Score | –4 | 2 | 0 | 1 | 1 | 0 | ||
Pre/intra-operative Definition | No Infection | LG-PJI | LG-PJI | LG-PJI | LG-PJI | LG-PJI | ||
Surgical procedure | One-stage knee revision | Two-stage knee revision | Two-stage hip revision | Two-stage knee revision | Two-stage knee revision | |||
Post-operative cultural examination | Negative | Negative | Negative | Negative | Negative | Negative | ||
Post-operative histology | Positive | Negative | Negative | Negative | Negative | Negative |
HG-PJI | LG-PJI | BIM | Contamination | No Infection | |
---|---|---|---|---|---|
n = 76 | n = 46 | n = 22 | n = 6 | n = 60 | |
(n and %) | (n and %) | (n and %) | (n and %) | (n and %) | |
Coagulase-negative Staphylococci | 28 (31.5) | 15 (53.6) | 11 (55) | 3 (42.9) | |
Staphylococcus aureus | 25 (28.1) | 4 (14.3) | 1 (14.3) | ||
Streptococci spp. | 12 (13.5) | 1 (3.6) | |||
Enterococci spp. | 6 (6.7) | 1 (3.6) | |||
Candida spp. | 4 (4.5) | 1 (3.6) | |||
Pseudomonas aeruginosa | 3 (3.4) | 3 (10.7) | |||
Propionibacterium acnes | 2 (2.2) | 2 (7.1) | 5 (25) | 1 (14.3) | |
Escherichia coli (1 ESBL +) | 3 (3.3) | 1 (5) | |||
Citrobacter koseri | 2 (2.2) | ||||
Enterobacter | 1 (1.1) | ||||
Klebsiella oxytoca | 1 (1.1) | ||||
Bacillus lentus | 1 (5) | ||||
Corynebacterium | 1 (1.1) | 1 (5) | 1 (14.3) | ||
Micrococci | 1 (1.1) | 1 (3.6) | 1 (5) | 1 (14.3) | |
TOTAL | 89 (100) | 28 (100) | 20 (100) | 7 (100) | |
Patients with a mixed flora | 10 (13.2) | 0 | 3 (13.6) | 1 (16.7) | |
Patients with negative cultures | 2 (2.6) | 17 (37) | 5 (22.7) | 0 | 60 (100) |
No Infection | Contamination | BIM | LG-PJI | HG-PJI | |
---|---|---|---|---|---|
Clinical presentation | One or more condition(s), other than infection, can cause the symptoms or the reason for reoperation (e.g., wear debris, metallosis, recurrent dislocation or joint instability, fracture, malposition, neuropathic pain) | Sinus tract or exposed implant, or ≥1 of the followings: otherwise “unexplained” pain, swelling, stiffness | Sinus tract or exposed implant or ≥2 of the followings: pain, swelling, redness, warmth, Functio laesa | ||
Positive rule in minus Negative rule out tests | <0 | <0 | <0 | ≥0 | ≥1 |
Post-operatively confirmed if | Negative cultural examination | One pre- or intra-operative positive culture, with negative histology | Positive cultural examination (preferably with anti-biofilm techniques) and/or positive histology |
Definition. | Rule In Tests | Rule Out Tests |
---|---|---|
Clinical examination | Draining sinus or exposed joint prosthesis * | |
Serum | IL-6 (>10 pg/mL) ** PC (>0.5 ng/mL) ** D-Dimer (>850 ng/mL) ** | ESR (>30 mm/h) *** CRP (>10 mg/L) *** |
Synovial fluid | Cultural examination ** WBC (>3000/mL) ** LE (++) ** AD immuunoassay (>5.2 mg/L) or lateral flow test ** | WBC (>1500/μL) *** LE (++) *** AD immunoassay (>5.2 mg/L) *** |
Imaging | Combined leukocyte and bone marrow scintigraphy ** | Tc99 bone scan *** |
Histology | Frozen section (5 neutrophils in ≥3 HPFs ** |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bozhkova, S.; Suardi, V.; Sharma, H.K.; Tsuchiya, H.; del Sel, H.; Hafez, M.A.; Benzakour, T.; Drago, L.; Romanò, C.L., on behalf of The World Association against Infection in Orthopedics and Trauma (W.A.I.O.T.) Study Group on Bone and Joint Infection Definitions. The W.A.I.O.T. Definition of Peri-Prosthetic Joint Infection: A Multi-center, Retrospective Validation Study. J. Clin. Med. 2020, 9, 1965. https://doi.org/10.3390/jcm9061965
Bozhkova S, Suardi V, Sharma HK, Tsuchiya H, del Sel H, Hafez MA, Benzakour T, Drago L, Romanò CL on behalf of The World Association against Infection in Orthopedics and Trauma (W.A.I.O.T.) Study Group on Bone and Joint Infection Definitions. The W.A.I.O.T. Definition of Peri-Prosthetic Joint Infection: A Multi-center, Retrospective Validation Study. Journal of Clinical Medicine. 2020; 9(6):1965. https://doi.org/10.3390/jcm9061965
Chicago/Turabian StyleBozhkova, Svetlana, Virginia Suardi, Hemant K Sharma, Hiroyuki Tsuchiya, Hernán del Sel, Mahmoud A. Hafez, Thami Benzakour, Lorenzo Drago, and Carlo Luca Romanò on behalf of The World Association against Infection in Orthopedics and Trauma (W.A.I.O.T.) Study Group on Bone and Joint Infection Definitions. 2020. "The W.A.I.O.T. Definition of Peri-Prosthetic Joint Infection: A Multi-center, Retrospective Validation Study" Journal of Clinical Medicine 9, no. 6: 1965. https://doi.org/10.3390/jcm9061965
APA StyleBozhkova, S., Suardi, V., Sharma, H. K., Tsuchiya, H., del Sel, H., Hafez, M. A., Benzakour, T., Drago, L., & Romanò, C. L., on behalf of The World Association against Infection in Orthopedics and Trauma (W.A.I.O.T.) Study Group on Bone and Joint Infection Definitions. (2020). The W.A.I.O.T. Definition of Peri-Prosthetic Joint Infection: A Multi-center, Retrospective Validation Study. Journal of Clinical Medicine, 9(6), 1965. https://doi.org/10.3390/jcm9061965